Table of Content

1 Intravenous Immunoglobulin(IVIg) Therapy Market Overview
1.1 Product Overview and Scope of Intravenous Immunoglobulin(IVIg) Therapy
1.2 Intravenous Immunoglobulin(IVIg) Therapy Segment by Type
1.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Value Comparison by Type (2024-2034)
1.2.2 1g/20ml
1.2.3 1.25g/25ml
1.2.4 2.5g/50ml
1.2.5 5g/100ml
1.2.6 10g/200ml
1.2.7 Others
1.3 Intravenous Immunoglobulin(IVIg) Therapy Segment by Application
1.3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Value by Application: (2024-2034)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.3.5 Others
1.4 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Estimates and Forecasts
1.4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue 2024-2034
1.4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales 2024-2034
1.4.3 Global Intravenous Immunoglobulin(IVIg) Therapy Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Intravenous Immunoglobulin(IVIg) Therapy Market Competition by Manufacturers
2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Manufacturers (2024-2024)
2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturers (2024-2024)
2.4 Global Intravenous Immunoglobulin(IVIg) Therapy Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy, Product Type & Application
2.7 Intravenous Immunoglobulin(IVIg) Therapy Market Competitive Situation and Trends
2.7.1 Intravenous Immunoglobulin(IVIg) Therapy Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous Immunoglobulin(IVIg) Therapy Players Market Share by Revenue
2.7.3 Global Intravenous Immunoglobulin(IVIg) Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Immunoglobulin(IVIg) Therapy Retrospective Market Scenario by Region
3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region: 2024-2034
3.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region: 2024-2024
3.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region: 2024-2034
3.3 Global Intravenous Immunoglobulin(IVIg) Therapy Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region: 2024-2034
3.3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region: 2024-2024
3.3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region: 2024-2034
3.4 North America Intravenous Immunoglobulin(IVIg) Therapy Market Facts & Figures by Country
3.4.1 North America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2024-2034)
3.4.3 North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Facts & Figures by Country
3.5.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2024-2034)
3.5.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2024-2034)
3.6.3 Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intravenous Immunoglobulin(IVIg) Therapy Market Facts & Figures by Country
3.7.1 Latin America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2024-2034)
3.7.3 Latin America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2024-2034)
3.8.3 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2024-2034)
4.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2024-2024)
4.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2024-2034)
4.1.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2024-2034)
4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2024-2034)
4.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2024-2024)
4.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2024-2034)
4.2.3 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2024-2034)
4.3 Global Intravenous Immunoglobulin(IVIg) Therapy Price by Type (2024-2034)
5 Segment by Application
5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2024-2034)
5.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2024-2024)
5.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2024-2034)
5.1.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2024-2034)
5.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2024-2034)
5.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2024-2024)
5.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2024-2034)
5.2.3 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2024-2034)
5.3 Global Intravenous Immunoglobulin(IVIg) Therapy Price by Application (2024-2034)
6 Key Companies Profiled
6.1 TEIJIN LIMITED
6.1.1 TEIJIN LIMITED Corporation Information
6.1.2 TEIJIN LIMITED Description and Business Overview
6.1.3 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.1.4 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.1.5 TEIJIN LIMITED Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Biotest
6.3.1 Biotest Corporation Information
6.3.2 Biotest Description and Business Overview
6.3.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.3.5 Biotest Recent Developments/Updates
6.4 Kamada
6.4.1 Kamada Corporation Information
6.4.2 Kamada Description and Business Overview
6.4.3 Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Kamada Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.4.5 Kamada Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Corporation Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 Octapharma
6.6.1 Octapharma Corporation Information
6.6.2 Octapharma Description and Business Overview
6.6.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.6.5 Octapharma Recent Developments/Updates
6.7 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.7.5 Kedrion Recent Developments/Updates
6.8 LFB Group
6.8.1 LFB Group Corporation Information
6.8.2 LFB Group Description and Business Overview
6.8.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.8.4 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.8.5 LFB Group Recent Developments/Updates
6.9 Baxter
6.9.1 Baxter Corporation Information
6.9.2 Baxter Description and Business Overview
6.9.3 Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Baxter Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.9.5 Baxter Recent Developments/Updates
6.10 Nanyue Biopharming
6.10.1 Nanyue Biopharming Corporation Information
6.10.2 Nanyue Biopharming Description and Business Overview
6.10.3 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.10.5 Nanyue Biopharming Recent Developments/Updates
6.11 Boya-Bio
6.11.1 Boya-Bio Corporation Information
6.11.2 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.11.3 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.11.5 Boya-Bio Recent Developments/Updates
6.12 CSL Plasma
6.12.1 CSL Plasma Corporation Information
6.12.2 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.12.3 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.12.4 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.12.5 CSL Plasma Recent Developments/Updates
6.13 CNBG
6.13.1 CNBG Corporation Information
6.13.2 CNBG Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.13.3 CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.13.4 CNBG Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.13.5 CNBG Recent Developments/Updates
6.14 Beijing Tiantan Biological Products
6.14.1 Beijing Tiantan Biological Products Corporation Information
6.14.2 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.14.3 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.14.5 Beijing Tiantan Biological Products Recent Developments/Updates
6.15 Hualan Bio
6.15.1 Hualan Bio Corporation Information
6.15.2 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.15.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.15.5 Hualan Bio Recent Developments/Updates
6.16 Guangdong Shuagnlin Bio-pharmacy
6.16.1 Guangdong Shuagnlin Bio-pharmacy Corporation Information
6.16.2 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.16.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.16.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
6.17 Weiguang Biological
6.17.1 Weiguang Biological Corporation Information
6.17.2 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.17.3 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.17.4 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.17.5 Weiguang Biological Recent Developments/Updates
6.18 Sinopharm
6.18.1 Sinopharm Corporation Information
6.18.2 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.18.3 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.18.4 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.18.5 Sinopharm Recent Developments/Updates
6.19 Shanghai RAAS
6.19.1 Shanghai RAAS Corporation Information
6.19.2 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.19.3 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.19.4 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.19.5 Shanghai RAAS Recent Developments/Updates
6.20 Taibang Biologic Group
6.20.1 Taibang Biologic Group Corporation Information
6.20.2 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.20.3 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2024-2024)
6.20.4 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.20.5 Taibang Biologic Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Immunoglobulin(IVIg) Therapy Industry Chain Analysis
7.2 Intravenous Immunoglobulin(IVIg) Therapy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Immunoglobulin(IVIg) Therapy Production Mode & Process
7.4 Intravenous Immunoglobulin(IVIg) Therapy Sales and Marketing
7.4.1 Intravenous Immunoglobulin(IVIg) Therapy Sales Channels
7.4.2 Intravenous Immunoglobulin(IVIg) Therapy Distributors
7.5 Intravenous Immunoglobulin(IVIg) Therapy Customers
8 Intravenous Immunoglobulin(IVIg) Therapy Market Dynamics
8.1 Intravenous Immunoglobulin(IVIg) Therapy Industry Trends
8.2 Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
8.3 Intravenous Immunoglobulin(IVIg) Therapy Market Challenges
8.4 Intravenous Immunoglobulin(IVIg) Therapy Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Intravenous Immunoglobulin(IVIg) Therapy Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Intravenous Immunoglobulin(IVIg) Therapy Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Intravenous Immunoglobulin(IVIg) Therapy Market Competitive Situation by Manufacturers in 2022
Table 4. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Intravenous Immunoglobulin(IVIg) Therapy Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Intravenous Immunoglobulin(IVIg) Therapy, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intravenous Immunoglobulin(IVIg) Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin(IVIg) Therapy as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2024-2024) & (K Units)
Table 18. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2024-2024)
Table 19. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2024-2034) & (K Units)
Table 20. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2024-2034)
Table 21. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2024-2024)
Table 23. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2024-2034)
Table 25. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2024-2024) & (K Units)
Table 27. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2024-2034) & (K Units)
Table 28. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2024-2024) & (K Units)
Table 32. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2024-2034) & (K Units)
Table 33. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units) by Type (2024-2024)
Table 51. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units) by Type (2024-2034)
Table 52. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2024-2024)
Table 53. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2024-2034)
Table 54. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2024-2024)
Table 57. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2024-2034)
Table 58. Global Intravenous Immunoglobulin(IVIg) Therapy Price (US$/Unit) by Type (2024-2024)
Table 59. Global Intravenous Immunoglobulin(IVIg) Therapy Price (US$/Unit) by Type (2024-2034)
Table 60. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units) by Application (2024-2024)
Table 61. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units) by Application (2024-2034)
Table 62. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2024-2024)
Table 63. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2024-2034)
Table 64. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2024-2024)
Table 67. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2024-2034)
Table 68. Global Intravenous Immunoglobulin(IVIg) Therapy Price (US$/Unit) by Application (2024-2024)
Table 69. Global Intravenous Immunoglobulin(IVIg) Therapy Price (US$/Unit) by Application (2024-2034)
Table 70. TEIJIN LIMITED Corporation Information
Table 71. TEIJIN LIMITED Description and Business Overview
Table 72. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product
Table 74. TEIJIN LIMITED Recent Developments/Updates
Table 75. Grifols Corporation Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product
Table 79. Grifols Recent Developments/Updates
Table 80. Biotest Corporation Information
Table 81. Biotest Description and Business Overview
Table 82. Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product
Table 84. Biotest Recent Developments/Updates
Table 85. Kamada Corporation Information
Table 86. Kamada Description and Business Overview
Table 87. Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Kamada Intravenous Immunoglobulin(IVIg) Therapy Product
Table 89. Kamada Recent Developments/Updates
Table 90. Takeda Corporation Information
Table 91. Takeda Description and Business Overview
Table 92. Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product
Table 94. Takeda Recent Developments/Updates
Table 95. Octapharma Corporation Information
Table 96. Octapharma Description and Business Overview
Table 97. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product
Table 99. Octapharma Recent Developments/Updates
Table 100. Kedrion Corporation Information
Table 101. Kedrion Description and Business Overview
Table 102. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product
Table 104. Kedrion Recent Developments/Updates
Table 105. LFB Group Corporation Information
Table 106. LFB Group Description and Business Overview
Table 107. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product
Table 109. LFB Group Recent Developments/Updates
Table 110. Baxter Corporation Information
Table 111. Baxter Description and Business Overview
Table 112. Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Baxter Intravenous Immunoglobulin(IVIg) Therapy Product
Table 114. Baxter Recent Developments/Updates
Table 115. Nanyue Biopharming Corporation Information
Table 116. Nanyue Biopharming Description and Business Overview
Table 117. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product
Table 119. Nanyue Biopharming Recent Developments/Updates
Table 120. Boya-Bio Corporation Information
Table 121. Boya-Bio Description and Business Overview
Table 122. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product
Table 124. Boya-Bio Recent Developments/Updates
Table 125. CSL Plasma Corporation Information
Table 126. CSL Plasma Description and Business Overview
Table 127. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product
Table 129. CSL Plasma Recent Developments/Updates
Table 130. CNBG Corporation Information
Table 131. CNBG Description and Business Overview
Table 132. CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. CNBG Intravenous Immunoglobulin(IVIg) Therapy Product
Table 134. CNBG Recent Developments/Updates
Table 135. Beijing Tiantan Biological Products Corporation Information
Table 136. Beijing Tiantan Biological Products Description and Business Overview
Table 137. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product
Table 139. Beijing Tiantan Biological Products Recent Developments/Updates
Table 140. Hualan Bio Corporation Information
Table 141. Hualan Bio Description and Business Overview
Table 142. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product
Table 144. Hualan Bio Recent Developments/Updates
Table 145. Guangdong Shuagnlin Bio-pharmacy Corporation Information
Table 146. Guangdong Shuagnlin Bio-pharmacy Description and Business Overview
Table 147. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product
Table 149. Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
Table 150. Weiguang Biological Corporation Information
Table 151. Weiguang Biological Description and Business Overview
Table 152. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product
Table 154. Weiguang Biological Recent Developments/Updates
Table 155. Sinopharm Corporation Information
Table 156. Sinopharm Description and Business Overview
Table 157. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product
Table 159. Sinopharm Recent Developments/Updates
Table 160. Shanghai RAAS Corporation Information
Table 161. Shanghai RAAS Description and Business Overview
Table 162. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 163. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product
Table 164. Shanghai RAAS Recent Developments/Updates
Table 165. Taibang Biologic Group Corporation Information
Table 166. Taibang Biologic Group Description and Business Overview
Table 167. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 168. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product
Table 169. Taibang Biologic Group Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Intravenous Immunoglobulin(IVIg) Therapy Distributors List
Table 173. Intravenous Immunoglobulin(IVIg) Therapy Customers List
Table 174. Intravenous Immunoglobulin(IVIg) Therapy Market Trends
Table 175. Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
Table 176. Intravenous Immunoglobulin(IVIg) Therapy Market Challenges
Table 177. Intravenous Immunoglobulin(IVIg) Therapy Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intravenous Immunoglobulin(IVIg) Therapy
Figure 2. Global Intravenous Immunoglobulin(IVIg) Therapy Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Intravenous Immunoglobulin(IVIg) Therapy Market Share by Type in 2022 & 2034
Figure 4. 1g/20ml Product Picture
Figure 5. 1.25g/25ml Product Picture
Figure 6. 2.5g/50ml Product Picture
Figure 7. 5g/100ml Product Picture
Figure 8. 10g/200ml Product Picture
Figure 9. Others Product Picture
Figure 10. Global Intravenous Immunoglobulin(IVIg) Therapy Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Intravenous Immunoglobulin(IVIg) Therapy Market Share by Application in 2022 & 2034
Figure 12. Immunodeficiency
Figure 13. Autoimmune Disease
Figure 14. Acute Infection
Figure 15. Others
Figure 16. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 17. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size (2024-2034) & (US$ Million)
Figure 18. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (2024-2034) & (K Units)
Figure 19. Global Intravenous Immunoglobulin(IVIg) Therapy Average Price (US$/Unit) & (2024-2034)
Figure 20. Intravenous Immunoglobulin(IVIg) Therapy Report Years Considered
Figure 21. Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Manufacturers in 2022
Figure 22. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Manufacturers in 2022
Figure 23. The Global 5 and 10 Largest Intravenous Immunoglobulin(IVIg) Therapy Players: Market Share by Revenue in 2022
Figure 24. Intravenous Immunoglobulin(IVIg) Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 25. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 26. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2024-2034)
Figure 27. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2024-2034)
Figure 28. United States Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. Canada Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2024-2034)
Figure 31. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2024-2034)
Figure 32. Germany Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. France Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. U.K. Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Italy Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Russia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2024-2034)
Figure 38. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2024-2034)
Figure 39. China Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Japan Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. South Korea Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. India Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Australia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. China Taiwan Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Southeast Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2024-2034)
Figure 47. Latin America Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2024-2034)
Figure 48. Mexico Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Brazil Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Argentina Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2024-2034)
Figure 52. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2024-2034)
Figure 53. Turkey Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. UAE Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 56. Global Sales Market Share of Intravenous Immunoglobulin(IVIg) Therapy by Type (2024-2034)
Figure 57. Global Revenue Market Share of Intravenous Immunoglobulin(IVIg) Therapy by Type (2024-2034)
Figure 58. Global Intravenous Immunoglobulin(IVIg) Therapy Price (US$/Unit) by Type (2024-2034)
Figure 59. Global Sales Market Share of Intravenous Immunoglobulin(IVIg) Therapy by Application (2024-2034)
Figure 60. Global Revenue Market Share of Intravenous Immunoglobulin(IVIg) Therapy by Application (2024-2034)
Figure 61. Global Intravenous Immunoglobulin(IVIg) Therapy Price (US$/Unit) by Application (2024-2034)
Figure 62. Intravenous Immunoglobulin(IVIg) Therapy Value Chain
Figure 63. Intravenous Immunoglobulin(IVIg) Therapy Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed